Global BCG Vaccine for Tuberculosis (TB) Market Research Report 2024(Status and Outlook)
Report Overview:
BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.
The Global BCG Vaccine for Tuberculosis (TB) Market Size was estimated at USD 397.17 million in 2023 and is projected to reach USD 550.75 million by 2029, exhibiting a CAGR of 5.60% during the forecast period.
This report provides a deep insight into the global BCG Vaccine for Tuberculosis (TB) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global BCG Vaccine for Tuberculosis (TB) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the BCG Vaccine for Tuberculosis (TB) market in any manner.
Global BCG Vaccine for Tuberculosis (TB) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
Intervax
GSBPL
Statens Serum Institute
Biomed Lublin
ANLIS Malbran
Fundaз?o Ataulpho de Paiva
BB-NCIPD
Taj Pharmaceuticals
Bio Farma
Microgen
Torlakinstitut
Institut Pasteur de Tunis
IVAC
Market Segmentation (by Type)
Immune Type
Therapy Type
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the BCG Vaccine for Tuberculosis (TB) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.
The Global BCG Vaccine for Tuberculosis (TB) Market Size was estimated at USD 397.17 million in 2023 and is projected to reach USD 550.75 million by 2029, exhibiting a CAGR of 5.60% during the forecast period.
This report provides a deep insight into the global BCG Vaccine for Tuberculosis (TB) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global BCG Vaccine for Tuberculosis (TB) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the BCG Vaccine for Tuberculosis (TB) market in any manner.
Global BCG Vaccine for Tuberculosis (TB) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
Intervax
GSBPL
Statens Serum Institute
Biomed Lublin
ANLIS Malbran
Fundaз?o Ataulpho de Paiva
BB-NCIPD
Taj Pharmaceuticals
Bio Farma
Microgen
Torlakinstitut
Institut Pasteur de Tunis
IVAC
Market Segmentation (by Type)
Immune Type
Therapy Type
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the BCG Vaccine for Tuberculosis (TB) Market
- Overview of the regional outlook of the BCG Vaccine for Tuberculosis (TB) Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the BCG Vaccine for Tuberculosis (TB) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of BCG Vaccine for Tuberculosis (TB)
1.2 Key Market Segments
1.2.1 BCG Vaccine for Tuberculosis (TB) Segment by Type
1.2.2 BCG Vaccine for Tuberculosis (TB) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global BCG Vaccine for Tuberculosis (TB) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET COMPETITIVE LANDSCAPE
3.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Manufacturers (2019-2024)
3.2 Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Manufacturers (2019-2024)
3.3 BCG Vaccine for Tuberculosis (TB) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global BCG Vaccine for Tuberculosis (TB) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers BCG Vaccine for Tuberculosis (TB) Sales Sites, Area Served, Product Type
3.6 BCG Vaccine for Tuberculosis (TB) Market Competitive Situation and Trends
3.6.1 BCG Vaccine for Tuberculosis (TB) Market Concentration Rate
3.6.2 Global 5 and 10 Largest BCG Vaccine for Tuberculosis (TB) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BCG VACCINE FOR TUBERCULOSIS (TB) INDUSTRY CHAIN ANALYSIS
4.1 BCG Vaccine for Tuberculosis (TB) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BCG VACCINE FOR TUBERCULOSIS (TB) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2019-2024)
6.3 Global BCG Vaccine for Tuberculosis (TB) Market Size Market Share by Type (2019-2024)
6.4 Global BCG Vaccine for Tuberculosis (TB) Price by Type (2019-2024)
7 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global BCG Vaccine for Tuberculosis (TB) Market Sales by Application (2019-2024)
7.3 Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) by Application (2019-2024)
7.4 Global BCG Vaccine for Tuberculosis (TB) Sales Growth Rate by Application (2019-2024)
8 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET SEGMENTATION BY REGION
8.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Region
8.1.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Region
8.1.2 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region
8.2 North America
8.2.1 North America BCG Vaccine for Tuberculosis (TB) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe BCG Vaccine for Tuberculosis (TB) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America BCG Vaccine for Tuberculosis (TB) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck BCG Vaccine for Tuberculosis (TB) Basic Information
9.1.2 Merck BCG Vaccine for Tuberculosis (TB) Product Overview
9.1.3 Merck BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck BCG Vaccine for Tuberculosis (TB) SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Sanofi Pasteur
9.2.1 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Basic Information
9.2.2 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product Overview
9.2.3 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.2.4 Sanofi Pasteur Business Overview
9.2.5 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) SWOT Analysis
9.2.6 Sanofi Pasteur Recent Developments
9.3 Japan BCG Lab
9.3.1 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Basic Information
9.3.2 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Overview
9.3.3 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.3.4 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) SWOT Analysis
9.3.5 Japan BCG Lab Business Overview
9.3.6 Japan BCG Lab Recent Developments
9.4 China National Biotec
9.4.1 China National Biotec BCG Vaccine for Tuberculosis (TB) Basic Information
9.4.2 China National Biotec BCG Vaccine for Tuberculosis (TB) Product Overview
9.4.3 China National Biotec BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.4.4 China National Biotec Business Overview
9.4.5 China National Biotec Recent Developments
9.5 AJ Vaccines
9.5.1 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Basic Information
9.5.2 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Overview
9.5.3 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.5.4 AJ Vaccines Business Overview
9.5.5 AJ Vaccines Recent Developments
9.6 Serum Institute of India
9.6.1 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Basic Information
9.6.2 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Overview
9.6.3 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.6.4 Serum Institute of India Business Overview
9.6.5 Serum Institute of India Recent Developments
9.7 Intervax
9.7.1 Intervax BCG Vaccine for Tuberculosis (TB) Basic Information
9.7.2 Intervax BCG Vaccine for Tuberculosis (TB) Product Overview
9.7.3 Intervax BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.7.4 Intervax Business Overview
9.7.5 Intervax Recent Developments
9.8 GSBPL
9.8.1 GSBPL BCG Vaccine for Tuberculosis (TB) Basic Information
9.8.2 GSBPL BCG Vaccine for Tuberculosis (TB) Product Overview
9.8.3 GSBPL BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.8.4 GSBPL Business Overview
9.8.5 GSBPL Recent Developments
9.9 Statens Serum Institute
9.9.1 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Basic Information
9.9.2 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product Overview
9.9.3 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.9.4 Statens Serum Institute Business Overview
9.9.5 Statens Serum Institute Recent Developments
9.10 Biomed Lublin
9.10.1 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Basic Information
9.10.2 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Overview
9.10.3 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.10.4 Biomed Lublin Business Overview
9.10.5 Biomed Lublin Recent Developments
9.11 ANLIS Malbran
9.11.1 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Basic Information
9.11.2 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Overview
9.11.3 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.11.4 ANLIS Malbran Business Overview
9.11.5 ANLIS Malbran Recent Developments
9.12 Fundaз?o Ataulpho de Paiva
9.12.1 Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Basic Information
9.12.2 Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Overview
9.12.3 Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.12.4 Fundaз?o Ataulpho de Paiva Business Overview
9.12.5 Fundaз?o Ataulpho de Paiva Recent Developments
9.13 BB-NCIPD
9.13.1 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Basic Information
9.13.2 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Overview
9.13.3 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.13.4 BB-NCIPD Business Overview
9.13.5 BB-NCIPD Recent Developments
9.14 Taj Pharmaceuticals
9.14.1 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Basic Information
9.14.2 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Overview
9.14.3 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.14.4 Taj Pharmaceuticals Business Overview
9.14.5 Taj Pharmaceuticals Recent Developments
9.15 Bio Farma
9.15.1 Bio Farma BCG Vaccine for Tuberculosis (TB) Basic Information
9.15.2 Bio Farma BCG Vaccine for Tuberculosis (TB) Product Overview
9.15.3 Bio Farma BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.15.4 Bio Farma Business Overview
9.15.5 Bio Farma Recent Developments
9.16 Microgen
9.16.1 Microgen BCG Vaccine for Tuberculosis (TB) Basic Information
9.16.2 Microgen BCG Vaccine for Tuberculosis (TB) Product Overview
9.16.3 Microgen BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.16.4 Microgen Business Overview
9.16.5 Microgen Recent Developments
9.17 Torlakinstitut
9.17.1 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Basic Information
9.17.2 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Overview
9.17.3 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.17.4 Torlakinstitut Business Overview
9.17.5 Torlakinstitut Recent Developments
9.18 Institut Pasteur de Tunis
9.18.1 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Basic Information
9.18.2 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Overview
9.18.3 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.18.4 Institut Pasteur de Tunis Business Overview
9.18.5 Institut Pasteur de Tunis Recent Developments
9.19 IVAC
9.19.1 IVAC BCG Vaccine for Tuberculosis (TB) Basic Information
9.19.2 IVAC BCG Vaccine for Tuberculosis (TB) Product Overview
9.19.3 IVAC BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.19.4 IVAC Business Overview
9.19.5 IVAC Recent Developments
10 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET FORECAST BY REGION
10.1 Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast
10.2 Global BCG Vaccine for Tuberculosis (TB) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country
10.2.3 Asia Pacific BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Region
10.2.4 South America BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of BCG Vaccine for Tuberculosis (TB) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global BCG Vaccine for Tuberculosis (TB) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of BCG Vaccine for Tuberculosis (TB) by Type (2025-2030)
11.1.2 Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of BCG Vaccine for Tuberculosis (TB) by Type (2025-2030)
11.2 Global BCG Vaccine for Tuberculosis (TB) Market Forecast by Application (2025-2030)
11.2.1 Global BCG Vaccine for Tuberculosis (TB) Sales (Kilotons) Forecast by Application
11.2.2 Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of BCG Vaccine for Tuberculosis (TB)
1.2 Key Market Segments
1.2.1 BCG Vaccine for Tuberculosis (TB) Segment by Type
1.2.2 BCG Vaccine for Tuberculosis (TB) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global BCG Vaccine for Tuberculosis (TB) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET COMPETITIVE LANDSCAPE
3.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Manufacturers (2019-2024)
3.2 Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Manufacturers (2019-2024)
3.3 BCG Vaccine for Tuberculosis (TB) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global BCG Vaccine for Tuberculosis (TB) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers BCG Vaccine for Tuberculosis (TB) Sales Sites, Area Served, Product Type
3.6 BCG Vaccine for Tuberculosis (TB) Market Competitive Situation and Trends
3.6.1 BCG Vaccine for Tuberculosis (TB) Market Concentration Rate
3.6.2 Global 5 and 10 Largest BCG Vaccine for Tuberculosis (TB) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BCG VACCINE FOR TUBERCULOSIS (TB) INDUSTRY CHAIN ANALYSIS
4.1 BCG Vaccine for Tuberculosis (TB) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BCG VACCINE FOR TUBERCULOSIS (TB) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2019-2024)
6.3 Global BCG Vaccine for Tuberculosis (TB) Market Size Market Share by Type (2019-2024)
6.4 Global BCG Vaccine for Tuberculosis (TB) Price by Type (2019-2024)
7 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global BCG Vaccine for Tuberculosis (TB) Market Sales by Application (2019-2024)
7.3 Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) by Application (2019-2024)
7.4 Global BCG Vaccine for Tuberculosis (TB) Sales Growth Rate by Application (2019-2024)
8 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET SEGMENTATION BY REGION
8.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Region
8.1.1 Global BCG Vaccine for Tuberculosis (TB) Sales by Region
8.1.2 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region
8.2 North America
8.2.1 North America BCG Vaccine for Tuberculosis (TB) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe BCG Vaccine for Tuberculosis (TB) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America BCG Vaccine for Tuberculosis (TB) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck BCG Vaccine for Tuberculosis (TB) Basic Information
9.1.2 Merck BCG Vaccine for Tuberculosis (TB) Product Overview
9.1.3 Merck BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck BCG Vaccine for Tuberculosis (TB) SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Sanofi Pasteur
9.2.1 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Basic Information
9.2.2 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product Overview
9.2.3 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.2.4 Sanofi Pasteur Business Overview
9.2.5 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) SWOT Analysis
9.2.6 Sanofi Pasteur Recent Developments
9.3 Japan BCG Lab
9.3.1 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Basic Information
9.3.2 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Overview
9.3.3 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.3.4 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) SWOT Analysis
9.3.5 Japan BCG Lab Business Overview
9.3.6 Japan BCG Lab Recent Developments
9.4 China National Biotec
9.4.1 China National Biotec BCG Vaccine for Tuberculosis (TB) Basic Information
9.4.2 China National Biotec BCG Vaccine for Tuberculosis (TB) Product Overview
9.4.3 China National Biotec BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.4.4 China National Biotec Business Overview
9.4.5 China National Biotec Recent Developments
9.5 AJ Vaccines
9.5.1 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Basic Information
9.5.2 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Overview
9.5.3 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.5.4 AJ Vaccines Business Overview
9.5.5 AJ Vaccines Recent Developments
9.6 Serum Institute of India
9.6.1 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Basic Information
9.6.2 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Overview
9.6.3 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.6.4 Serum Institute of India Business Overview
9.6.5 Serum Institute of India Recent Developments
9.7 Intervax
9.7.1 Intervax BCG Vaccine for Tuberculosis (TB) Basic Information
9.7.2 Intervax BCG Vaccine for Tuberculosis (TB) Product Overview
9.7.3 Intervax BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.7.4 Intervax Business Overview
9.7.5 Intervax Recent Developments
9.8 GSBPL
9.8.1 GSBPL BCG Vaccine for Tuberculosis (TB) Basic Information
9.8.2 GSBPL BCG Vaccine for Tuberculosis (TB) Product Overview
9.8.3 GSBPL BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.8.4 GSBPL Business Overview
9.8.5 GSBPL Recent Developments
9.9 Statens Serum Institute
9.9.1 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Basic Information
9.9.2 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product Overview
9.9.3 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.9.4 Statens Serum Institute Business Overview
9.9.5 Statens Serum Institute Recent Developments
9.10 Biomed Lublin
9.10.1 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Basic Information
9.10.2 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Overview
9.10.3 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.10.4 Biomed Lublin Business Overview
9.10.5 Biomed Lublin Recent Developments
9.11 ANLIS Malbran
9.11.1 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Basic Information
9.11.2 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Overview
9.11.3 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.11.4 ANLIS Malbran Business Overview
9.11.5 ANLIS Malbran Recent Developments
9.12 Fundaз?o Ataulpho de Paiva
9.12.1 Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Basic Information
9.12.2 Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Overview
9.12.3 Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.12.4 Fundaз?o Ataulpho de Paiva Business Overview
9.12.5 Fundaз?o Ataulpho de Paiva Recent Developments
9.13 BB-NCIPD
9.13.1 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Basic Information
9.13.2 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Overview
9.13.3 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.13.4 BB-NCIPD Business Overview
9.13.5 BB-NCIPD Recent Developments
9.14 Taj Pharmaceuticals
9.14.1 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Basic Information
9.14.2 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Overview
9.14.3 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.14.4 Taj Pharmaceuticals Business Overview
9.14.5 Taj Pharmaceuticals Recent Developments
9.15 Bio Farma
9.15.1 Bio Farma BCG Vaccine for Tuberculosis (TB) Basic Information
9.15.2 Bio Farma BCG Vaccine for Tuberculosis (TB) Product Overview
9.15.3 Bio Farma BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.15.4 Bio Farma Business Overview
9.15.5 Bio Farma Recent Developments
9.16 Microgen
9.16.1 Microgen BCG Vaccine for Tuberculosis (TB) Basic Information
9.16.2 Microgen BCG Vaccine for Tuberculosis (TB) Product Overview
9.16.3 Microgen BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.16.4 Microgen Business Overview
9.16.5 Microgen Recent Developments
9.17 Torlakinstitut
9.17.1 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Basic Information
9.17.2 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Overview
9.17.3 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.17.4 Torlakinstitut Business Overview
9.17.5 Torlakinstitut Recent Developments
9.18 Institut Pasteur de Tunis
9.18.1 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Basic Information
9.18.2 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Overview
9.18.3 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.18.4 Institut Pasteur de Tunis Business Overview
9.18.5 Institut Pasteur de Tunis Recent Developments
9.19 IVAC
9.19.1 IVAC BCG Vaccine for Tuberculosis (TB) Basic Information
9.19.2 IVAC BCG Vaccine for Tuberculosis (TB) Product Overview
9.19.3 IVAC BCG Vaccine for Tuberculosis (TB) Product Market Performance
9.19.4 IVAC Business Overview
9.19.5 IVAC Recent Developments
10 BCG VACCINE FOR TUBERCULOSIS (TB) MARKET FORECAST BY REGION
10.1 Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast
10.2 Global BCG Vaccine for Tuberculosis (TB) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country
10.2.3 Asia Pacific BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Region
10.2.4 South America BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of BCG Vaccine for Tuberculosis (TB) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global BCG Vaccine for Tuberculosis (TB) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of BCG Vaccine for Tuberculosis (TB) by Type (2025-2030)
11.1.2 Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of BCG Vaccine for Tuberculosis (TB) by Type (2025-2030)
11.2 Global BCG Vaccine for Tuberculosis (TB) Market Forecast by Application (2025-2030)
11.2.1 Global BCG Vaccine for Tuberculosis (TB) Sales (Kilotons) Forecast by Application
11.2.2 Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. BCG Vaccine for Tuberculosis (TB) Market Size Comparison by Region (M USD)
Table 5. Global BCG Vaccine for Tuberculosis (TB) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global BCG Vaccine for Tuberculosis (TB) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global BCG Vaccine for Tuberculosis (TB) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG Vaccine for Tuberculosis (TB) as of 2022)
Table 10. Global Market BCG Vaccine for Tuberculosis (TB) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers BCG Vaccine for Tuberculosis (TB) Sales Sites and Area Served
Table 12. Manufacturers BCG Vaccine for Tuberculosis (TB) Product Type
Table 13. Global BCG Vaccine for Tuberculosis (TB) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of BCG Vaccine for Tuberculosis (TB)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. BCG Vaccine for Tuberculosis (TB) Market Challenges
Table 22. Global BCG Vaccine for Tuberculosis (TB) Sales by Type (Kilotons)
Table 23. Global BCG Vaccine for Tuberculosis (TB) Market Size by Type (M USD)
Table 24. Global BCG Vaccine for Tuberculosis (TB) Sales (Kilotons) by Type (2019-2024)
Table 25. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2019-2024)
Table 26. Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) by Type (2019-2024)
Table 27. Global BCG Vaccine for Tuberculosis (TB) Market Size Share by Type (2019-2024)
Table 28. Global BCG Vaccine for Tuberculosis (TB) Price (USD/Ton) by Type (2019-2024)
Table 29. Global BCG Vaccine for Tuberculosis (TB) Sales (Kilotons) by Application
Table 30. Global BCG Vaccine for Tuberculosis (TB) Market Size by Application
Table 31. Global BCG Vaccine for Tuberculosis (TB) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2019-2024)
Table 33. Global BCG Vaccine for Tuberculosis (TB) Sales by Application (2019-2024) & (M USD)
Table 34. Global BCG Vaccine for Tuberculosis (TB) Market Share by Application (2019-2024)
Table 35. Global BCG Vaccine for Tuberculosis (TB) Sales Growth Rate by Application (2019-2024)
Table 36. Global BCG Vaccine for Tuberculosis (TB) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2019-2024)
Table 38. North America BCG Vaccine for Tuberculosis (TB) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe BCG Vaccine for Tuberculosis (TB) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America BCG Vaccine for Tuberculosis (TB) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck BCG Vaccine for Tuberculosis (TB) Basic Information
Table 44. Merck BCG Vaccine for Tuberculosis (TB) Product Overview
Table 45. Merck BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck BCG Vaccine for Tuberculosis (TB) SWOT Analysis
Table 48. Merck Recent Developments
Table 49. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Basic Information
Table 50. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product Overview
Table 51. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Sanofi Pasteur Business Overview
Table 53. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) SWOT Analysis
Table 54. Sanofi Pasteur Recent Developments
Table 55. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Basic Information
Table 56. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Overview
Table 57. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) SWOT Analysis
Table 59. Japan BCG Lab Business Overview
Table 60. Japan BCG Lab Recent Developments
Table 61. China National Biotec BCG Vaccine for Tuberculosis (TB) Basic Information
Table 62. China National Biotec BCG Vaccine for Tuberculosis (TB) Product Overview
Table 63. China National Biotec BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. China National Biotec Business Overview
Table 65. China National Biotec Recent Developments
Table 66. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Basic Information
Table 67. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Overview
Table 68. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. AJ Vaccines Business Overview
Table 70. AJ Vaccines Recent Developments
Table 71. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Basic Information
Table 72. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Overview
Table 73. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Serum Institute of India Business Overview
Table 75. Serum Institute of India Recent Developments
Table 76. Intervax BCG Vaccine for Tuberculosis (TB) Basic Information
Table 77. Intervax BCG Vaccine for Tuberculosis (TB) Product Overview
Table 78. Intervax BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Intervax Business Overview
Table 80. Intervax Recent Developments
Table 81. GSBPL BCG Vaccine for Tuberculosis (TB) Basic Information
Table 82. GSBPL BCG Vaccine for Tuberculosis (TB) Product Overview
Table 83. GSBPL BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. GSBPL Business Overview
Table 85. GSBPL Recent Developments
Table 86. Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Basic Information
Table 87. Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product Overview
Table 88. Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Statens Serum Institute Business Overview
Table 90. Statens Serum Institute Recent Developments
Table 91. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Basic Information
Table 92. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Overview
Table 93. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Biomed Lublin Business Overview
Table 95. Biomed Lublin Recent Developments
Table 96. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Basic Information
Table 97. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Overview
Table 98. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. ANLIS Malbran Business Overview
Table 100. ANLIS Malbran Recent Developments
Table 101. Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Basic Information
Table 102. Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Overview
Table 103. Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Fundaз?o Ataulpho de Paiva Business Overview
Table 105. Fundaз?o Ataulpho de Paiva Recent Developments
Table 106. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Basic Information
Table 107. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Overview
Table 108. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. BB-NCIPD Business Overview
Table 110. BB-NCIPD Recent Developments
Table 111. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Basic Information
Table 112. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Overview
Table 113. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Taj Pharmaceuticals Business Overview
Table 115. Taj Pharmaceuticals Recent Developments
Table 116. Bio Farma BCG Vaccine for Tuberculosis (TB) Basic Information
Table 117. Bio Farma BCG Vaccine for Tuberculosis (TB) Product Overview
Table 118. Bio Farma BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Bio Farma Business Overview
Table 120. Bio Farma Recent Developments
Table 121. Microgen BCG Vaccine for Tuberculosis (TB) Basic Information
Table 122. Microgen BCG Vaccine for Tuberculosis (TB) Product Overview
Table 123. Microgen BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Microgen Business Overview
Table 125. Microgen Recent Developments
Table 126. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Basic Information
Table 127. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Overview
Table 128. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Torlakinstitut Business Overview
Table 130. Torlakinstitut Recent Developments
Table 131. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Basic Information
Table 132. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Overview
Table 133. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Institut Pasteur de Tunis Business Overview
Table 135. Institut Pasteur de Tunis Recent Developments
Table 136. IVAC BCG Vaccine for Tuberculosis (TB) Basic Information
Table 137. IVAC BCG Vaccine for Tuberculosis (TB) Product Overview
Table 138. IVAC BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. IVAC Business Overview
Table 140. IVAC Recent Developments
Table 141. Global BCG Vaccine for Tuberculosis (TB) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 142. Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America BCG Vaccine for Tuberculosis (TB) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 144. North America BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe BCG Vaccine for Tuberculosis (TB) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 146. Europe BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 148. Asia Pacific BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America BCG Vaccine for Tuberculosis (TB) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 150. South America BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global BCG Vaccine for Tuberculosis (TB) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 154. Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global BCG Vaccine for Tuberculosis (TB) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 156. Global BCG Vaccine for Tuberculosis (TB) Sales (Kilotons) Forecast by Application (2025-2030)
Table 157. Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. BCG Vaccine for Tuberculosis (TB) Market Size Comparison by Region (M USD)
Table 5. Global BCG Vaccine for Tuberculosis (TB) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global BCG Vaccine for Tuberculosis (TB) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global BCG Vaccine for Tuberculosis (TB) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG Vaccine for Tuberculosis (TB) as of 2022)
Table 10. Global Market BCG Vaccine for Tuberculosis (TB) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers BCG Vaccine for Tuberculosis (TB) Sales Sites and Area Served
Table 12. Manufacturers BCG Vaccine for Tuberculosis (TB) Product Type
Table 13. Global BCG Vaccine for Tuberculosis (TB) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of BCG Vaccine for Tuberculosis (TB)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. BCG Vaccine for Tuberculosis (TB) Market Challenges
Table 22. Global BCG Vaccine for Tuberculosis (TB) Sales by Type (Kilotons)
Table 23. Global BCG Vaccine for Tuberculosis (TB) Market Size by Type (M USD)
Table 24. Global BCG Vaccine for Tuberculosis (TB) Sales (Kilotons) by Type (2019-2024)
Table 25. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2019-2024)
Table 26. Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) by Type (2019-2024)
Table 27. Global BCG Vaccine for Tuberculosis (TB) Market Size Share by Type (2019-2024)
Table 28. Global BCG Vaccine for Tuberculosis (TB) Price (USD/Ton) by Type (2019-2024)
Table 29. Global BCG Vaccine for Tuberculosis (TB) Sales (Kilotons) by Application
Table 30. Global BCG Vaccine for Tuberculosis (TB) Market Size by Application
Table 31. Global BCG Vaccine for Tuberculosis (TB) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2019-2024)
Table 33. Global BCG Vaccine for Tuberculosis (TB) Sales by Application (2019-2024) & (M USD)
Table 34. Global BCG Vaccine for Tuberculosis (TB) Market Share by Application (2019-2024)
Table 35. Global BCG Vaccine for Tuberculosis (TB) Sales Growth Rate by Application (2019-2024)
Table 36. Global BCG Vaccine for Tuberculosis (TB) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2019-2024)
Table 38. North America BCG Vaccine for Tuberculosis (TB) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe BCG Vaccine for Tuberculosis (TB) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America BCG Vaccine for Tuberculosis (TB) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck BCG Vaccine for Tuberculosis (TB) Basic Information
Table 44. Merck BCG Vaccine for Tuberculosis (TB) Product Overview
Table 45. Merck BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck BCG Vaccine for Tuberculosis (TB) SWOT Analysis
Table 48. Merck Recent Developments
Table 49. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Basic Information
Table 50. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product Overview
Table 51. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Sanofi Pasteur Business Overview
Table 53. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) SWOT Analysis
Table 54. Sanofi Pasteur Recent Developments
Table 55. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Basic Information
Table 56. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Overview
Table 57. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) SWOT Analysis
Table 59. Japan BCG Lab Business Overview
Table 60. Japan BCG Lab Recent Developments
Table 61. China National Biotec BCG Vaccine for Tuberculosis (TB) Basic Information
Table 62. China National Biotec BCG Vaccine for Tuberculosis (TB) Product Overview
Table 63. China National Biotec BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. China National Biotec Business Overview
Table 65. China National Biotec Recent Developments
Table 66. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Basic Information
Table 67. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Overview
Table 68. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. AJ Vaccines Business Overview
Table 70. AJ Vaccines Recent Developments
Table 71. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Basic Information
Table 72. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Overview
Table 73. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Serum Institute of India Business Overview
Table 75. Serum Institute of India Recent Developments
Table 76. Intervax BCG Vaccine for Tuberculosis (TB) Basic Information
Table 77. Intervax BCG Vaccine for Tuberculosis (TB) Product Overview
Table 78. Intervax BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Intervax Business Overview
Table 80. Intervax Recent Developments
Table 81. GSBPL BCG Vaccine for Tuberculosis (TB) Basic Information
Table 82. GSBPL BCG Vaccine for Tuberculosis (TB) Product Overview
Table 83. GSBPL BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. GSBPL Business Overview
Table 85. GSBPL Recent Developments
Table 86. Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Basic Information
Table 87. Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product Overview
Table 88. Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Statens Serum Institute Business Overview
Table 90. Statens Serum Institute Recent Developments
Table 91. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Basic Information
Table 92. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Overview
Table 93. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Biomed Lublin Business Overview
Table 95. Biomed Lublin Recent Developments
Table 96. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Basic Information
Table 97. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Overview
Table 98. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. ANLIS Malbran Business Overview
Table 100. ANLIS Malbran Recent Developments
Table 101. Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Basic Information
Table 102. Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Overview
Table 103. Fundaз?o Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Fundaз?o Ataulpho de Paiva Business Overview
Table 105. Fundaз?o Ataulpho de Paiva Recent Developments
Table 106. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Basic Information
Table 107. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Overview
Table 108. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. BB-NCIPD Business Overview
Table 110. BB-NCIPD Recent Developments
Table 111. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Basic Information
Table 112. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Overview
Table 113. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Taj Pharmaceuticals Business Overview
Table 115. Taj Pharmaceuticals Recent Developments
Table 116. Bio Farma BCG Vaccine for Tuberculosis (TB) Basic Information
Table 117. Bio Farma BCG Vaccine for Tuberculosis (TB) Product Overview
Table 118. Bio Farma BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Bio Farma Business Overview
Table 120. Bio Farma Recent Developments
Table 121. Microgen BCG Vaccine for Tuberculosis (TB) Basic Information
Table 122. Microgen BCG Vaccine for Tuberculosis (TB) Product Overview
Table 123. Microgen BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Microgen Business Overview
Table 125. Microgen Recent Developments
Table 126. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Basic Information
Table 127. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Overview
Table 128. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Torlakinstitut Business Overview
Table 130. Torlakinstitut Recent Developments
Table 131. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Basic Information
Table 132. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Overview
Table 133. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Institut Pasteur de Tunis Business Overview
Table 135. Institut Pasteur de Tunis Recent Developments
Table 136. IVAC BCG Vaccine for Tuberculosis (TB) Basic Information
Table 137. IVAC BCG Vaccine for Tuberculosis (TB) Product Overview
Table 138. IVAC BCG Vaccine for Tuberculosis (TB) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. IVAC Business Overview
Table 140. IVAC Recent Developments
Table 141. Global BCG Vaccine for Tuberculosis (TB) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 142. Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Region (2025-2030) & (M USD)
Table 143. North America BCG Vaccine for Tuberculosis (TB) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 144. North America BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country (2025-2030) & (M USD)
Table 145. Europe BCG Vaccine for Tuberculosis (TB) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 146. Europe BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country (2025-2030) & (M USD)
Table 147. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 148. Asia Pacific BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Region (2025-2030) & (M USD)
Table 149. South America BCG Vaccine for Tuberculosis (TB) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 150. South America BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country (2025-2030) & (M USD)
Table 151. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Consumption Forecast by Country (2025-2030) & (Units)
Table 152. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Country (2025-2030) & (M USD)
Table 153. Global BCG Vaccine for Tuberculosis (TB) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 154. Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Type (2025-2030) & (M USD)
Table 155. Global BCG Vaccine for Tuberculosis (TB) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 156. Global BCG Vaccine for Tuberculosis (TB) Sales (Kilotons) Forecast by Application (2025-2030)
Table 157. Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of BCG Vaccine for Tuberculosis (TB)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD), 2019-2030
Figure 5. Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) (2019-2030)
Figure 6. Global BCG Vaccine for Tuberculosis (TB) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. BCG Vaccine for Tuberculosis (TB) Market Size by Country (M USD)
Figure 11. BCG Vaccine for Tuberculosis (TB) Sales Share by Manufacturers in 2023
Figure 12. Global BCG Vaccine for Tuberculosis (TB) Revenue Share by Manufacturers in 2023
Figure 13. BCG Vaccine for Tuberculosis (TB) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market BCG Vaccine for Tuberculosis (TB) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by BCG Vaccine for Tuberculosis (TB) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global BCG Vaccine for Tuberculosis (TB) Market Share by Type
Figure 18. Sales Market Share of BCG Vaccine for Tuberculosis (TB) by Type (2019-2024)
Figure 19. Sales Market Share of BCG Vaccine for Tuberculosis (TB) by Type in 2023
Figure 20. Market Size Share of BCG Vaccine for Tuberculosis (TB) by Type (2019-2024)
Figure 21. Market Size Market Share of BCG Vaccine for Tuberculosis (TB) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global BCG Vaccine for Tuberculosis (TB) Market Share by Application
Figure 24. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2019-2024)
Figure 25. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application in 2023
Figure 26. Global BCG Vaccine for Tuberculosis (TB) Market Share by Application (2019-2024)
Figure 27. Global BCG Vaccine for Tuberculosis (TB) Market Share by Application in 2023
Figure 28. Global BCG Vaccine for Tuberculosis (TB) Sales Growth Rate by Application (2019-2024)
Figure 29. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2019-2024)
Figure 30. North America BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country in 2023
Figure 32. U.S. BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada BCG Vaccine for Tuberculosis (TB) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico BCG Vaccine for Tuberculosis (TB) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country in 2023
Figure 37. Germany BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region in 2023
Figure 44. China BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (Kilotons)
Figure 50. South America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country in 2023
Figure 51. Brazil BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global BCG Vaccine for Tuberculosis (TB) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global BCG Vaccine for Tuberculosis (TB) Market Share Forecast by Type (2025-2030)
Figure 65. Global BCG Vaccine for Tuberculosis (TB) Sales Forecast by Application (2025-2030)
Figure 66. Global BCG Vaccine for Tuberculosis (TB) Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of BCG Vaccine for Tuberculosis (TB)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD), 2019-2030
Figure 5. Global BCG Vaccine for Tuberculosis (TB) Market Size (M USD) (2019-2030)
Figure 6. Global BCG Vaccine for Tuberculosis (TB) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. BCG Vaccine for Tuberculosis (TB) Market Size by Country (M USD)
Figure 11. BCG Vaccine for Tuberculosis (TB) Sales Share by Manufacturers in 2023
Figure 12. Global BCG Vaccine for Tuberculosis (TB) Revenue Share by Manufacturers in 2023
Figure 13. BCG Vaccine for Tuberculosis (TB) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market BCG Vaccine for Tuberculosis (TB) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by BCG Vaccine for Tuberculosis (TB) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global BCG Vaccine for Tuberculosis (TB) Market Share by Type
Figure 18. Sales Market Share of BCG Vaccine for Tuberculosis (TB) by Type (2019-2024)
Figure 19. Sales Market Share of BCG Vaccine for Tuberculosis (TB) by Type in 2023
Figure 20. Market Size Share of BCG Vaccine for Tuberculosis (TB) by Type (2019-2024)
Figure 21. Market Size Market Share of BCG Vaccine for Tuberculosis (TB) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global BCG Vaccine for Tuberculosis (TB) Market Share by Application
Figure 24. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2019-2024)
Figure 25. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application in 2023
Figure 26. Global BCG Vaccine for Tuberculosis (TB) Market Share by Application (2019-2024)
Figure 27. Global BCG Vaccine for Tuberculosis (TB) Market Share by Application in 2023
Figure 28. Global BCG Vaccine for Tuberculosis (TB) Sales Growth Rate by Application (2019-2024)
Figure 29. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2019-2024)
Figure 30. North America BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country in 2023
Figure 32. U.S. BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada BCG Vaccine for Tuberculosis (TB) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico BCG Vaccine for Tuberculosis (TB) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country in 2023
Figure 37. Germany BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region in 2023
Figure 44. China BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (Kilotons)
Figure 50. South America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country in 2023
Figure 51. Brazil BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa BCG Vaccine for Tuberculosis (TB) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global BCG Vaccine for Tuberculosis (TB) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global BCG Vaccine for Tuberculosis (TB) Market Share Forecast by Type (2025-2030)
Figure 65. Global BCG Vaccine for Tuberculosis (TB) Sales Forecast by Application (2025-2030)
Figure 66. Global BCG Vaccine for Tuberculosis (TB) Market Share Forecast by Application (2025-2030)
